Fredun Pharmaceuticals Performance
- Today's Low
- ₹2,475
- Today's High
- ₹2,620
- 52 Week Low
- ₹690
- 52 Week High
- ₹2,620
- Open Price₹2,580
- Previous Close₹2,553
- Volume9,719
- 50 DMA₹2,089.71
- 100 DMA₹1,891.70
- 200 DMA₹1,646.12
Fredun Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 18.44%
- Over 3 Month + 49.96%
- Over 6 Month + 34.17%
- Over 1 Year + 239.54%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 35
- PEG Ratio
- 0.4
- Market Cap Cr
- 1,190
- P/B Ratio
- 7.1
- Average True Range
- 149.87
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 142.23
- RSI
- 66.91
- MFI
- 70.49
Latest Stock News Updates
Stable outlook reflects improving credit quality amid export expansion across Africa, Southeast Asia, CIS and Latin America
- Business Line
- 2 months 3 weeks ago
First batch of Snacky Jain a Jain functional food for pets sells out through pre-orders
- Business Line
- 6 months 1 week ago
Developed through in-house R&D, Snacky Jain combines natural, plant-based ingredients with functional health benefits, ensuring both taste and wellness for companion animals
- Business Line
- 7 months 1 week ago
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹2,322.64
- 50 Day
- ₹2,089.71
- 100 Day
- ₹1,891.70
- 200 Day
- ₹1,646.12
Resistance and Support
- R3 2,752.48
- R2 2,686.22
- R1 2,607.53
- S1 2,462.58
- S2 2,396.32
- S3 2,317.63
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-25 | Audited Results, Dividend & Bonus issue | |
| 2026-02-09 | Quarterly Results | |
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results |
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Popular Stocks
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹2,500 As on 25 May, 2026 | 05:20
The Market Cap of Fredun Pharmaceuticals is ₹1190.4 Cr As on 25 May, 2026 | 05:20
The P/E ratio of Fredun Pharmaceuticals is 35 As on 25 May, 2026 | 05:20
The PB ratio of Fredun Pharmaceuticals is 7.1 As on 25 May, 2026 | 05:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.